Step 2

BIOLOGICAL2 trials

Sponsors

Green Cross Corporation, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions

Haematological MalignanciesInfluenzaSarcomas

Phase 1

Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

CompletedNCT01389466

Green Cross CorporationInfluenza

Start: 2010-02-28End: 2011-12-31Updated: 2014-11-21

Unknown Phase

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

RecruitingNCT06829654

IRCCS Azienda Ospedaliero-Universitaria di BolognaHaematological Malignancies, Sarcomas

Start: 2024-08-12End: 2026-08-12Target: 80Updated: 2025-02-17